Obstructive Sleep Apnoea in Children and Adolescents with Ehlers-Danlos Syndrome.


Journal

Respiration; international review of thoracic diseases
ISSN: 1423-0356
Titre abrégé: Respiration
Pays: Switzerland
ID NLM: 0137356

Informations de publication

Date de publication:
Historique:
received: 25 07 2018
accepted: 05 10 2018
pubmed: 30 11 2018
medline: 22 8 2020
entrez: 29 11 2018
Statut: ppublish

Résumé

In Ehlers-Danlos syndrome (EDS), a group of monogenic disorders affecting connective tissues, obstructive sleep apnoea (OSA) is highly prevalent in adults. The prevalence of OSA in children with EDS is unknown. This prospective cross-sectional study aimed at determining the prevalence of OSA in paediatric EDS patients. Children with EDS (n = 24) were recruited from the Children's Hospital Zurich and matched to healthy controls. Participants completed home respiratory polygraphy and questionnaires (Sleep-Related Breathing Disorder Scale [SRBD], Epworth Sleepiness Scale [ESS], and Child Health Questionnaire [CHQ]). The American Academy of Sleep Medicine criteria were applied for OSA diagnosis (obstructive apnoea-hypopnoea index [oAHI] ≥1/h). Conditional logistic regression was used to compare the prevalence of OSA and to adjust for possible confounding. OSA was found in 42% of paediatric EDS patients and in 13% of matched controls (OR = 4.5, 95% CI = 0.97-20.83, p = 0.054). The median oAHI was higher in EDS patients than in controls (0.77/h, IQR = 0.19-1.76, vs. 0.24/h, IQR = 0.0-0.60, p < 0.001 adjusted for age, sex, and BMI z-score). EDS patients had lower scores in most CHQ scales and higher SRBD and ESS scores than controls (0.26, IQR = 0.1-0.35, vs. 0.07, IQR = 0-0.19, p = 0.004); 7 ± 4 vs. 5 ± 4, p = 0.033, respectively). OSA is a previously underestimated EDS-related complication increasing disease burden.

Sections du résumé

BACKGROUND BACKGROUND
In Ehlers-Danlos syndrome (EDS), a group of monogenic disorders affecting connective tissues, obstructive sleep apnoea (OSA) is highly prevalent in adults. The prevalence of OSA in children with EDS is unknown.
OBJECTIVES OBJECTIVE
This prospective cross-sectional study aimed at determining the prevalence of OSA in paediatric EDS patients.
METHODS METHODS
Children with EDS (n = 24) were recruited from the Children's Hospital Zurich and matched to healthy controls. Participants completed home respiratory polygraphy and questionnaires (Sleep-Related Breathing Disorder Scale [SRBD], Epworth Sleepiness Scale [ESS], and Child Health Questionnaire [CHQ]). The American Academy of Sleep Medicine criteria were applied for OSA diagnosis (obstructive apnoea-hypopnoea index [oAHI] ≥1/h). Conditional logistic regression was used to compare the prevalence of OSA and to adjust for possible confounding.
RESULTS RESULTS
OSA was found in 42% of paediatric EDS patients and in 13% of matched controls (OR = 4.5, 95% CI = 0.97-20.83, p = 0.054). The median oAHI was higher in EDS patients than in controls (0.77/h, IQR = 0.19-1.76, vs. 0.24/h, IQR = 0.0-0.60, p < 0.001 adjusted for age, sex, and BMI z-score). EDS patients had lower scores in most CHQ scales and higher SRBD and ESS scores than controls (0.26, IQR = 0.1-0.35, vs. 0.07, IQR = 0-0.19, p = 0.004); 7 ± 4 vs. 5 ± 4, p = 0.033, respectively).
CONCLUSION CONCLUSIONS
OSA is a previously underestimated EDS-related complication increasing disease burden.

Identifiants

pubmed: 30485858
pii: 000494328
doi: 10.1159/000494328
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

284-291

Informations de copyright

© 2018 S. Karger AG, Basel.

Auteurs

Anna S Stöberl (AS)

Department of Pulmonology, University Hospital Zurich, Zurich, Switzerland.

Thomas Gaisl (T)

Department of Pulmonology, University Hospital Zurich, Zurich, Switzerland.

Cecilia Giunta (C)

Connective Tissue Unit, Division of Metabolism and Children's Research Centre, University Children's Hospital, Zurich, Switzerland.

Noriane A Sievi (NA)

Department of Pulmonology, University Hospital Zurich, Zurich, Switzerland.

Florian Singer (F)

Division of Respiratory Medicine, University Children's Hospital Zurich, Zurich, Switzerland.

Alexander Möller (A)

Division of Respiratory Medicine, University Children's Hospital Zurich, Zurich, Switzerland.
Centre for Interdisciplinary Sleep Research, University of Zurich, Zurich, Switzerland.

Marianne Rohrbach (M)

Connective Tissue Unit, Division of Metabolism and Children's Research Centre, University Children's Hospital, Zurich, Switzerland.

Malcolm Kohler (M)

Department of Pulmonology, University Hospital Zurich, Zurich, Switzerland, Malcolm.Kohler@usz.ch.
Centre for Interdisciplinary Sleep Research, University of Zurich, Zurich, Switzerland, Malcolm.Kohler@usz.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH